Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BMEA |
---|---|---|
09:32 ET | 6213 | 12.2 |
09:34 ET | 4375 | 12.145 |
09:36 ET | 1500 | 12.12 |
09:38 ET | 777 | 12.13 |
09:39 ET | 100 | 12.18 |
09:41 ET | 100 | 12.17 |
09:43 ET | 19445 | 12.41 |
09:45 ET | 1552 | 12.49 |
09:48 ET | 2037 | 12.595 |
09:50 ET | 900 | 12.46 |
09:52 ET | 700 | 12.47 |
09:54 ET | 500 | 12.51 |
09:56 ET | 2851 | 12.44 |
09:57 ET | 1500 | 12.47 |
09:59 ET | 950 | 12.53 |
10:01 ET | 1100 | 12.48 |
10:03 ET | 1325 | 12.535 |
10:06 ET | 822 | 12.6 |
10:08 ET | 1799 | 12.59 |
10:10 ET | 2153 | 12.48 |
10:12 ET | 2100 | 12.46 |
10:14 ET | 800 | 12.38 |
10:15 ET | 500 | 12.375 |
10:17 ET | 4364 | 12.3745 |
10:21 ET | 1483 | 12.41 |
10:24 ET | 880 | 12.37 |
10:26 ET | 811 | 12.35 |
10:28 ET | 1552 | 12.42 |
10:30 ET | 1519 | 12.45 |
10:32 ET | 2591 | 12.42 |
10:33 ET | 1697 | 12.39 |
10:35 ET | 843 | 12.43 |
10:37 ET | 1344 | 12.45 |
10:39 ET | 300 | 12.452 |
10:42 ET | 2498 | 12.54 |
10:44 ET | 350 | 12.5 |
10:46 ET | 889 | 12.49 |
10:48 ET | 600 | 12.52 |
10:50 ET | 2400 | 12.5 |
10:51 ET | 200 | 12.485 |
10:53 ET | 1539 | 12.5 |
10:55 ET | 500 | 12.51 |
10:57 ET | 600 | 12.505 |
11:00 ET | 500 | 12.52 |
11:02 ET | 1200 | 12.49 |
11:04 ET | 350 | 12.4925 |
11:06 ET | 910 | 12.51 |
11:08 ET | 1076 | 12.52 |
11:09 ET | 100 | 12.52 |
11:11 ET | 1200 | 12.52 |
11:13 ET | 788 | 12.46 |
11:15 ET | 400 | 12.475 |
11:18 ET | 8038 | 12.518 |
11:20 ET | 100 | 12.5 |
11:24 ET | 750 | 12.55 |
11:26 ET | 400 | 12.565 |
11:27 ET | 100 | 12.565 |
11:29 ET | 4494 | 12.59 |
11:31 ET | 3499 | 12.61 |
11:33 ET | 100 | 12.61 |
11:36 ET | 1218 | 12.584 |
11:38 ET | 1215 | 12.62 |
11:40 ET | 400 | 12.62 |
11:42 ET | 300 | 12.61 |
11:44 ET | 500 | 12.6 |
11:45 ET | 400 | 12.625 |
11:49 ET | 900 | 12.6 |
11:51 ET | 844 | 12.66 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Biomea Fusion Inc | 440.0M | -3.6x | --- |
ACELYRIN Inc | 434.2M | -1.7x | --- |
Neurogene Inc | 432.4M | -7.5x | --- |
PepGen Inc | 426.3M | -4.0x | --- |
Lexeo Therapeutics Inc | 456.3M | -5.2x | --- |
Nkarta Inc | 460.2M | -2.9x | --- |
Biomea Fusion, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of oral covalent small molecules to treat patients with metabolic diseases and genetically defined cancers. A covalent small molecule is a synthetic compound that forms a permanent bond to its target protein. The Company is utilizing its proprietary FUSION System to discover, design and develop a pipeline of covalent-binding small molecule medicines designed to maximize clinical benefit for patients. Its lead product candidate, BMF-219, is designed to be an oral, potent, and selective covalent inhibitor of menin, built from its FUSION System. It is developing BMF-219 for the treatment of menin regulated or dependent diseases, such as type 1 and type 2 diabetes as well as subtypes of liquid and solid tumors. Its second development candidate, BMF-500, a covalent inhibitor of activating mutations of the FMS-like tyrosine kinase 3 (FLT3).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $440.0M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 35.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-3.57 |
Book Value | $4.72 |
P/E Ratio | -3.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.